Application of static magnetic fields versus copper for the relief of pain in osteoarthritis: a randomised double-blind placebo controlled trial | Not Recruiting
Application of static magnetic fields versus copper for the relief of pain in osteoarthritis: a randomised double-blind placebo controlled trial
MACROPOD (Magnetic And Copper therapy for the Relief Of Pain in Osteoarthritis: a randomised Double-blind placebo-controlled trial)
Trial Source

There is no location for this trial

Location data is sourced from multiple external providers and UKCTG is not responsible for and cannot guarantee the accuracy of data.

Health Conditions
  • Osteoarthritis
Mr Stewart Richmond
+44 (0)1482 463681
See all trial contact details
Primary Contact Details
Not Recruiting
Recruitment Status
ISRCTN18518978
Primary Trial ID Number
Summary
Not provided at time of registration
Research Details
  • This trial aims to investigate the therapeutic efficacy of commercially available magnetic and copper bracelets as an adjunct to practitioner led management of osteoarthritic pain. Additional aims are to evaluate the potential economic impact of static magnetic therapy (SMT) and to gather evidence relating to safety of the devices under investigation. This will help to address both local and more widespread needs in terms of providing rigorous scientific evidence relating to the efficacy of magnetic and copper bracelets.
Phase
Not Specified
Study Design
Randomised double-blind placebo controlled trial
Study Type
Interventional
Intervention

The trial will use a randomised double-blind placebo controlled crossover design. All participants will undertake one of four randomly allocated treatment sequences consisting of four phases (one active and three control). During the active phase participants will wear the MagnaMax® static magnetic device for a period of four weeks. During the three control (placebo) phases, which will each last for four weeks, all participants will in turn wear: an otherwise identical low strength static magnetic device, a demagnetised device and a copper bracelet.

Intervention Type
Other
Primary Outcome Measures
  • Not provided at time of registration
Secondary Outcome Measures
  • Not provided at time of registration
Publication(s)
Sorry, this information is not available
Result Reports
Sorry, this information is not available
Gender
Not Specified
Age Range
Adult
Who Can Participate
Patient
Number of Participants
Between 48 to 60 patients identified as suffering from osteoarthritis within primary care.
Participant Inclusion Criteria
  • 1. 18 years of age or over
  • 2. Diagnosis of osteoarthritis
  • 3. In receipt of prescribed non-steroidal anti-inflammatory drugs (NSAIDs) and opioid/opioid compound analgesic medication
  • 4. Responsible for administering own medication
  • 5. Reporting pain associated with osteoarthritis
Participant Exclusion Criteria
  • 1. Confounding medical condition/disease
  • 2. Pain lasting less than 6 weeks in total duration prior to recruitment
  • 3. Pacemaker, insulin pump or similar device fitted
  • 4. Pregnant women
Trial Location(s)
Department of Sports, Health & Exercise Science, University of Hull
Hull
Humberside
HU6 7RX
Trial Contact(s)
Primary Trial Contact
Mr Stewart Richmond
s.j.richmond@hull.ac.uk
+44 (0)1482 463681
Other Trial Contacts
Sorry, this information is not available
Countries Recruiting
United Kingdom
Scientific Title
Sorry, this information is not available
EudraCT Number
Sorry, this information is not available
Funder(s)
  • Wolds Primary Care Research Network (WOREN) and West Hull Primary Care Trust (uk)
Other Study ID Numbers
N/A
Sponsor(s)
The University of Hull (UK)
Key Dates

Recruitment Start Date

01 Jan 2005

Recruitment End Date

31 Dec 2007

Trial Start Date

01 Jan 2005

Trial End Date

31 Dec 2007

Date Assigned

06 Dec 2004

Last Updated

15 May 2014